色多多视频

Departments

医学部研究室一覧のイメージ
School of Medicine - Clinical Medicine

Diabetology and Endocrinology

Outline

Our department has a new structure as of January 2022. We are committed to promoting basic and clinical research to help diabetic patients lead a life equivalent to non-diabetic people. It is crucial to prevent complications. We will advocate for early therapeutic intervention to prevent cardiovascular complications and microvascular complications such as nephropathy. Moreover, we must aim to preserve and improve patients' quality of life through their diabetes care and treatment. As for research methods, continuing basic research using conventional mice and cells is essential, and we will actively conduct ethically-sound human studies to build evidence useful in daily clinical practice. In this process, we will apply various advanced clinical examination techniques and make full use of data analysis using digital devices and artificial intelligence in line with the current era. As a clinical department of a private medical university, we will continue to promote challenging and rewarding research for all department members.

Contact Information
TEL: 076-286-2211 / FAX: 076-286-6927
e-mail: endocrin@kanazawa-med.ac.jp

Faculty

Professor and Chair

Professor (Adjunct) 

Senior Assistant Professor

Senior Assistant Professor

Assistant Professor

YASUNAGA Yoko

Assistant Professor

IKOMA Maki

Assistant Professor

IKEBUCHI Ayaka

Assistant Professor

OZAWA Tsubasa

Adjunct Lecturer

KONISHI Kazunori

Adjunct Lecturer

SHIGIYAMA Fumika

Research Achievements

Empagliflozin versus sitagliptin for ameliorating intrahepatic lipid content and tissue-specific insulin sensitivity in patients with early-stage type 2 diabetes with nonalcoholic fatty liver disease: A prospective randomized study.
Hiruma S, Shigiyama F, Kumashiro N.
Diabetes Obes Metab. 25(6):1576-1588, 2023.

Cardiorenal outcomes with finerenone in Asian patients with chronic kidney disease and type 2 diabetes: a FIDELIO-DKD post hoc analysis.
Daisuke Koya, Stefan D Anker, Luis M Ruilope, Peter Rossing, ZhiHong Liu, Byung Wan Lee, Chien-Te Lee, Charlie Scott, 
Peter Kolkhof, Robert Lawatscheck, Lili Wang, Amer Joseph, Bertram Pitt; FIDELIO-DKD Investigators.
American Journal of Nephrology 54 (9-10):370-378, 2023.

Comparison of the effects of sitagliptin and dapagliflozin on time in range in Japanese patients with type 2 diabetes stratified by body mass index: a sub-analysis of the DIVERSITY-CVR study.
Kota Takuma, Ayako Fuchigami, Fumika Shigiyama, Naoki Kumashiro, Takahisa Hirose.
Diabetes, Obesity and metabolism 25(8):2131-2141, 2023.

Adenosine/adenosine type 1 receptor signaling pathway did not play dominant roles on the influence of sodium-glucose cotransporter 2 inhibitor in the kidney of bovine serum albumin-overloaded streptozotocin-induced diabetic mice.
Shimada K, Kanasaki K, Kato M, Ogura Y, Takagaki Y, Monno I, Hirai T, Kitada M, Koya D.
J Diabetes Investig. 2022 Jun;13(6):955-964.

A prospective randomized study comparing effects of empagliflozin to sitagliptin on cardiac fat accumulation, cardiac function,and cardiac metabolism in patients with early-stage type 2 diabetes: the ASSET study.
Hiruma S, Shigiyama F, Hisatake S, Mizumura S, Shiraga N, Hori M, Ikeda T, Hirose T, Kumashiro N.
Cardiovasc Diabetol. 2021 Feb 2;20(1):32.

External Research Funding

Manpei Suzuki Diabetes Foundation, Naoki Kumashiro, 2025

Grant-in-Aid for Scientific Research (C), Naoki Kumashiro, 2024-2026

Grant-in-Aid for Young Scientists, Fumika Shigiyama, 2022-2025

Links